We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Caplin Point Laboratories has announced that the US health regulator has made two observations after completion of inspection at it is subsidiary’s sterile injectable site in Tamil Nadu. The US Food and Drug Administration (US FDA) has completed inspectio